OraSure TechnologiesOSUR recently announced that it submitted two applications to the FDA seeking approval for its two new at ...

OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate ...

A 2022 study estimates that at-home flu tests have a sensitivity of about 63% if the test is performed within 72 hours of ...

In a study involving nearly 1,000 patients seen at a Baltimore field hospital during a five-month period in 2022, researchers at Johns Hopkins Medicine, the University of Maryland School of Medicine, ...

People can test themselves about as accurately at home with rapid antigen coronavirus tests as health care professionals using the same tests, according to a Johns Hopkins Medicine-led study published ...

The FDA has extended the shelf life for some COVID-19 tests. Now that allergy season is here, many are finding themselves with symptoms asking: Is it allergies or a cold? COVID? Something else? Since ...

Deependra Kumar Ban, Tyler Bodily, Abhijith G. Karkisaval, Yongliang Dong, Shreyam Natani, Anirudh Ramanathan, Armando Ramil, Sunil Srivastava, Prab Bandaru, Gennadi Glinsky, Ratnesh Lal Proceedings ...

WHO noted that prequalified tests can now be prioritized in pooled procurement mechanisms, which help lower prices, stabilize ...

The CLINITEST Rapid COVID-19 Antigen Self-Test has received FDA EUA for unsupervised self-testing for the SARS-CoV-2 virus by individuals age 14 and older (or adult-collected samples from individuals ...

Technologies submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration for clearance of its ...